Trump's Son-In-Law Back In Political Arena? Jared Kushner Reportedly Making Calls To Potential Donors To Attend Ex-President's New York Fundraiser For 2024 Run

On Monday, I will release a brand new Sniper Report Alert. A rare opportunity to get involved in what I believe is a heavily discounted stock.  You see, not too long ago this stock was destined to be acquired by Volkswagen. However, when the COVID-19 pandemic hit, the acquisition was put on ice. And since then, the stock has fallen nearly 50% from its expected deal price.  I think the deal will be re-announced very soon, and I am willing to put my own money where my mouth is.  You see, Volkswagen already has a substantial stake in this company, so it's unlikely they will walk away now.  But that's not the only reason why I'm betting on the acquisition.  For Volkswagen to claim dominance in the trucking pace, they need to scale globally.  And in order for them to achieve it, they'll need my latest Sniper Alert pick to make a meaningful footprint in Europe and North America.  Here's what Volkswagen's CFO had to say about the deal in mid-March, during the heart of the pandemic: "In terms of XXX, no, we've not pulled the deal. We still believe it is strategically a good idea."  If that's not compelling enough, on April 22nd I saw a massive options trade hit my scanner. A $622K bet that my latest Sniper Alert trade will trade significantly higher between now and the next six months.  These were out-the-money options purchased.  That means the trader needs to see the stock trade above their strike price or their $622K in premium will expire worthless. I wouldn't be surprised if it's someone who is intimate with the deal, and is betting it goes through.  I was ready to pull the trigger yesterday and buy the stock but felt I might be able to get better prices with Friday's market sell-off.  Plus I wanted you to have one more chance to examine the opportunity.  But I'm afraid if I wait any longer I'll miss this.  And in my opinion, this is a no-brainer.  This is just the fifth time I've issued a special Sniper Alert, the last four all played out beautifully, garnering total gains of more than 138%. But none of those were as clear as this one.  If you want in, it's simple— subscribe to the Sniper Report.  You'll not only get this pick, but you'll also get 12-months access to all my Sniper Report trades.  But you must hurry, after Sunday at midnight the price of Sniper Report goes back to its normal price of $997. Act now to receive my number #1 M&A trade of 2020 Don't be that person who plays the woulda coulda shoulda game.  I believe the market has given a gift.  Will you take it? Don't be left behind.  Kyle Dennis RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from kyle@biotechbreakouts.com Unsubscribe from all RagingBull emails Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative's own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.